VIVA Physicians Selects NAMSA as Statistical Analytic Group to Evaluate the Safety of Paclitaxel Drug-Eluting Technologies in PAD

By In The News
March 9, 2019 in The Headlines

Recommended Posts

In The News

Posted March 9, 2019

- Share

Posted March 9, 2019

SAN JOSE, Calif., March 8, 2019 /PRNewswire/ -- VIVA Physicians announced today the selection of NAMSA as the independent statistical analysis group to examine individual patient-level data (IPD) associated with paclitaxel-coated balloons and stent trials used in the treatment of...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  220716
2. Jaydee
  17227
3. deicer
  12610
4. Kip Powick
  12273
5. dagger
  9601
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  271.1k
- Total Posts
  
  561.2k

Sign In

VIVA Physicians Selects NAMSA as Statistical Analytic Group to Evaluate the Safety of Paclitaxel Drug-Eluting Technologies in PAD

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support